VSE knjižnice (vzajemna bibliografsko-kataložna baza podatkov COBIB.SI)
  • Very low-dose fluvastatin-valsartan combination decreases parameters of inflammation and oxidative stress in patients with type 1 diabetes mellitus
    Lunder, Mojca, dr. med., 1980- ...
    Aims Previously we revealed the effectiveness of a new therapeutic approach with a short-term, very-low dose fluvastatin-valsartan combination on the improvement of arterial function in type 1 ... diabetes mellitus patients (T1DM). In this study we explored whether this approach influences inflammation and oxidative stress and explored any association of these effects with arterial function improvement. Methods This was a supplementary analysis of the two previous double blind randomized studies (included 44 T1DM patients). Treatment group received very-low dose fluvastatin-valsartan, the control group received placebo. Blood samples were collected and inflammation parameters: high-sensitivity CRP (hsCRP), interleukin 6 (IL-6), vascular cell adhesion molecule-1 (VCAM-1) and oxidative stress parameter total antioxidant status (TAS) were measured. Results Treatment decreased hsCRP values (by 56.5%, P < 0.05) and IL-6 values (by 33.6%, P < 0.05) and increased TAS values (by 21.1%; P < 0.05) after 30 days of treatment. High sensitivity CRP and TAS remained decreased 3 months after treatment discontinuation. Importantly, the anti-inflammatory and anti-oxidative action significantly correlated with arterial function improvement. Conclusions The approach consisting of short-term (30 days) treatment with a very low-dose fluvastatin-valsartan combination acts anti-inflammatory and anti-oxidative in T1DM patients. These observations along with the improvement of arterial function support the assumption that this approach could have an important clinical benefit in T1DM patients.
    Vir: Diabetes research and clinical practice. - ISSN 0168-8227 (Vol. 127, May 2017, str. 181-186)
    Vrsta gradiva - članek, sestavni del
    Leto - 2017
    Jezik - angleški
    COBISS.SI-ID - 33170649